References
- 1. I. Singh, P. Kumar, N. Rani and V. Rana, Investigation of diff erent lipid based materials as matrices designed to control the release of a hydrophobic drug, Int. J. Pharm. Sci. Drug Res. 1 (2009) 158-163.
- 2. GATTEFOSSE, Lipid excipients for oral dosage forms, Documents for Oral route. h_ p://www.ga_ efosse. com/en/document-center/; last access July 15, 2013.
- 3. S. H. A. El-Halim, M. M. Amin, O. N. El-Gazayerly and N. A. A. El-Gavad, Comparative study on the diff erent techniques for the preparation of sustained-release hydrophobic matrices of a highly water-soluble drug, Drug Discov. Ther. 4 (2010) 484-492.
- 4. L. M. E. McIndoe, Glyceryl Dibehenate, in Handbook of Pharmaceutical Excipients (Eds. R. C. Rowe, P. J. Sheskey and S. C. Owen), 5th ed., Pharmaceutical Press, Washington 2006, pp. 304-305.
- 5. GATTEFOSSE, Developing sustained release tablets with CompritolR 888 ATO, Formulation Guidelines, Version 2, Lyon, 2010.
- 6. G. Ragnarsson, Force-displacement and Network Measurements, in Pharmaceutical Powder Compac tion Technology (Eds. G. Alderborn and Ch. Nystrom, Marcel Dekker Inc., New York 1996, pp. 77-96.
- 7. A. Stamm and C. Mathis, Verpressbarkeit von Festen Hilfsstoff en fur Direk_ able_ ierung, Acta Pharm. Technol. 22 (1976) 7-16.
- 8. J. T. Fell and J. M. Newton, Determination of tablet strength by diametral-compression test, J. Pharm. Sci. 59 (1970) 688-691; DOI: 10.1002/jps.2600590523.
- 9. European Pharmacopoeia, 7th ed., Vol. 1, Council of Europe, Strasbourg 2010, pp. 256-263.
- 10. V. A. Belousov, Choice of optimal pressure values in tableting medicinal powders, Khim. Farm. Zh. 10 (1976) 105-111.
- 11. B. A. C. Carlin, Direct Compression and the Role of Filler Binders, in Pharmaceutical Dosage Forms: Tablets, Eds. L. L. Augsburger and S. W. Hoag), 3th ed., Informa Healthcare USA, Inc., New York 2008, Vol. 2, pp. 173-216.
- 12. N. O. Iloanusi and J. B. Schwartz, The eff ect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization, Drug Dev. Ind. Pharm. 24 (1998) 37-44; DOI: 10.3109/03639049809082350.
- 13. M. Roberts, D. Vellucci, S. Mostafa, C. Miolane and D. Marchaud, Development and evaluation of sustained-release CompritolR 888 ATO matrix mini-tablets, Drug Dev. Ind. Pharm. 38 (2012) 1068-1076; DOI: 10.3109/03639045.2011.638302.
- 14. P. Costa and J. M. Sousa Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.